In trastuzumab-resistant breast cancer cell lines due to the PTEN deficiency, inhibition of PI3K pathway restores sensitivity to trastuzumab and significantly inhibits cell growth (Junttila et al., 2009). The gene discussed is PIK3CA; the disease is breast carcinoma.